A New UK 2006 National Kidney Allocation Scheme for deceased heart-beating donor kidneys

Area of Science:

• Nephrology
• Transplantation Immunology
• Public Health Policy

Background:

• Inequities in kidney transplant access from deceased donors were identified in the UK in 2004.
• A new allocation scheme was needed to address these disparities.
• Preparatory work involved reviewing human leukocyte antigen (HLA) matching criteria and simulating scheme effectiveness.

Purpose of the Study:

• To introduce and evaluate the 2006 National Kidney Allocation Scheme (NKAS).
• To improve equity in kidney transplant access for all patients.
• To optimize organ allocation based on patient and donor characteristics.

Main Methods:

• Implemented a points-based system prioritizing zero HLA-A, -B, -DR mismatches and pediatric patients.
• Integrated patient age and HLA matching scores, with less emphasis on HLA matching for older patients.
• Defaulted rare HLA specificities to common ones to aid difficult-to-match patients.

Main Results:

• After 3 years, the 2006 NKAS shows progress towards its objectives, aligning with simulation results.
• Significant benefits observed for patients with over 5 years on the waiting list.
• Improved equity in access, including for HLA-DR homozygous patients, though geographical inequities persist.

Conclusions:

• The 2006 NKAS is effectively improving equity in kidney transplant access in the UK.
• The scheme demonstrates success in prioritizing specific patient groups and addressing matching challenges.
• Ongoing efforts are needed to fully resolve geographical disparities in transplant access.